Majority of cancer patients with COVID-19 have similar immune response to people without cancer

(Albert Einstein College of Medicine) Most people with cancer who are infected by the novel coronavirus produce antibodies at a rate comparable to the rest of the population - but their ability to do so depends on their type of cancer and the treatments they've received, according to a new study by researchers at Montefiore Health System and Albert Einstein College of Medicine. The findings, published online today in Nature Cancer, may lead to better care for cancer patients, who face a heightened risk of dying from COVID-19, and suggests that cancer patients should respond well to COVID-19 vaccines.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news